The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tks Larry
https://twitter.com/Larry64450205/status/1449048950175117322
Thanks Larry/Wilson, good solid stuff, seems like goodbyes also to JTP!
Quite a few big snippets in here regarding US. Transplant diagnostics. 5mins on about two need projects. Along with automating surveillance. Very interesting.
Simple...they are all counting:)))) Have a good weekend all Monday may be interesting.
Whatched this a couple of times,maybe some posters claiming Nova has no future may think again,no debts,cash available for MA,s etc,The future,s bright the future is Nova,Gla.
Thanks for sharing it here Wilson.
Very good video imho
Why is Mullis in the video? Yesterday's CEO quite literally, surely they should presenting the new CEOs vision for our future direction with his face front and centre.
Also, why wasn't this released by the company at least through its Twitter account? They never miss an opportunity to miss, yet again it takes someone like Larry to somehow dig this out of the internet. Their pr have learned sfa.
Don't tell the market. The shares will be 20% more expensive to buy. I like accumulating at these prices.
Could be wrong but this video has not been done overnight,not sure if I seen GM doing same introduction/ending in previous by JTP, Could be wrong. rest of video is certainly encouraging market news,may have been orchestrated by our new Brush,roll on Monday,as Mama,s and Papa,s sang " Monday Monday,so Good To ME ",Hic,back to G&T,s.GLA.
You can date the vid from the bioinformatics tests 2mill now 3.5. I guess it was / is promotional material for the trade shows they are busy attending. Excellent vid though .
Maybe the most important part imho :
https://twitter.com/Larry64450205/status/1449080329227091969?t=tUhZOf-kpxsaga_7pzCIJQ&s=19
Agree
But does anyone know what's going on with Grahams beard and his other facial hair ?
Hmmm. a ten minute PCR test, now that would be something.
10 min PCR test = mid cap
Simple equation
Thats the standout to me , reckon they are on it already. Please tell me that gets you going Dunc :)
# me too they are who I'd love to see get a bonus.
Impressive stuff, they wouldn't have mentioned the 10 min PCR if it wasn't something they think they can't deliver.
This is what frustrates the hell out of me. They are honestly outstanding in their field, way ahead of everyone else, agile, nimble and consistently ahead of the game, all the major players are running to catch up but novacyt makes them look like they are standing still.
It's almost as if they are embarrassed by their development, the SP is in the bin. I just don't get it.
Other AIM companies would be shouting this from the rooftops.
I've given up trying to work this out, none of it makes any sense anymore.
Currently considering going sh1 t or bust and trying to average down but honestly I have no clue as to whats going to happen, my head says this is a massive opportunity but my heart is saying, don't lose anymore
Excellent video. Thanks for sharing
Poidster -
I would say don't make further decisions until after the AGM, and - if quorate - the EGM.
I expect further discussion of the subjects within the video at this meeting.
a) A new CEO should have something to say on future priorities, - possibly Marketing and sales.
b) Material that amplifies the video could be discussed.
The presentation backs up what appears in the 22.06.2021 RNS Novacyt-full-year-2020-results 'Strategy Update', so I'm thinking AD might further amplify at AGM.
Bullet points found within the Strategy Update:
• Investment in R&D to deliver new products in the respiratory and transplant
bacterial and viral diagnostic markets
• Investment in commercial infrastructure to establish a direct sales force in key
markets in Europe and the US
• Selective product/technology and company acquisitions to generate additional
revenues and expand its core capabilities whilst maintaining attractive margins
• Investment in developing new IP portfolio to enhance and secure future value
As you say sp in the bin, but not for much longer if M&A activity arrives.
The video contains this statement of intent that will wake up the competition:
"Guillermo Raimondo (3:06)
The focus for us going forward is to establish ourselves in the America's especially the US, and also to expand our global footprint, focusing on one of the key European markets."
IMO I expect US based competitors to allow us to invest in Novacyt US Inc as we have stated, then make any offer only when it becomes clear our global and/or US market share is increasing markedly.
If little increase in market share, then any predator offer might be because they covet our instrumentation, R&D, and Bioinformatics teams, to say nothing of the catalogue of Primer design assays and Microgen LFT's etc.
Novacyt cannot be ignored by competitors because the speed with which we innovate is a clear and present danger to competitor profits, if not now, then very possibly soon. The term 'market disruptive', applies to many of our products such as Q16/Q32, PROmate, SNP-sig assays, Escapeplex et al. They need more marketing spend to wake the market up to Navacyt's potential, and that will happen now DA has arrived.
@Poidster
Agree - so innovatiive and outstanding in their field yet difficult decisions to be made on a personal level regards investment. Maybe it's down to whether you have a better head or a better heart and sometimes it takes longer for the heart to catch up.
Regards marketing and improving sales, I think we are all able to play a small part in shouting this companies merits from the rooftops intead of continually moaning about our own personal circumstances on a daily basis.
Liked the video which exhibited an exuberant mix of youth, experience and ethnicity while focusing on the task in hand with great expectations and hope for the future. My main criticism would be around some areas which made some of the production methods look a bit like a cottage industry - which on reflection, given the situation in certain places, may be no bad thing.
@poidster I love reading your posts and agree wholeheartedly with your comments. Many on here are already stretched and over invested. Whilst I am behind Novacyt 100% I would urge you to move forward with caution. The anxiety and stress this depressed share price can cause is seen first hand on this board. I wish you well whatever you decide.
The comments in the video about bringing the processing time of a test down from 60 minutes to 10 minutes reminded me of this report from Birmingham University in August. They have developed a test which can show results in under 10 minutes and can be used on standard lab equipment.At the end of the article they mention that they are seeking partner's to bring the test to market .
Could Novacyt be working on a similar concept?
https://www.birmingham.ac.uk/news/latest/2021/08/birmingham-researchers-confirm-speed-simplicity-and-sensitivity-for-new-covid-19-test.aspx
some excellent comments made above...IMO, GM looks knackered.....for me hands down the near to patient testing in 10 mins will solve all our problems for large venue testing...there's a lot of coughing and spluttering going on and no one knows what they have.....and the icing on the cake is the talk about investment going into the USA and South America.....the yanks are keen to uptake European/ UK products very readily....seen it many a time in pharma....one sniff of success and NCYT will be bought in a flash !
@Kitzie
Hope you are right regards the U.S.A. and S.A.
However, why did that big roll of ' Fragile ' labels take centre stage at the relevant point in the video.
Not very subliminal - what was that all about ?
Could posters please refrain from making finger in the air cash at bank estimates in future, simply because it seems likely Novacyt income from assay sales and instruments must be increasing in line with other companies statements of being very busy lately.
The cost of setting up Novacyt US Inc cannot possibly be established because insufficient info concerning these costs is available in the public domain.
However, I accept we are totally committed to setting the company up after Raimondo's statement :
"The focus for us going forward is to establish ourselves in the America's especially the US, and also to expand our global footprint, focusing on one of the key European markets."
I'll raise a glass tonight to Kevin and Raimondo's efforts to get this business set up on a strong footing, such that we can see some action soon.